Parkinson's disease is characterised by non-motor symptoms including sleep and circadian 27 disruption, but the underlying aetiology is not well understood. Melanopsin-expressing 28 intrinsically photosensitive Retinal Ganglion Cells (ipRGC) transmit light signals from the 29 eye to brain areas controlling circadian rhythms and the pupil light reflex. Here we evaluate 30 the hypothesis that these non-motor symptoms in people with Parkinson's disease may be 31 linked to ipRGC dysfunction. Using chromatic pupillometry, we measured intrinsic 32 (melanopsin-mediated) ipRGC and extrinsic (rod/cone photoreceptor-mediated) inputs to the 33 pupil control pathway in a group of optimally medicated participants with a diagnosis of 34 Parkinson's disease (PD, n = 17) compared to controls (n = 12). Autonomic tone was 35 evaluated by measuring pupillary unrest in darkness. The PD participants underwent 36 additional clinical assessments using the Unified Parkinson's disease Rating Scale (UPDRS) 37 and the Hoehn and Yahr scale (H&Y). 38 Compared to controls, the PD group demonstrated an attenuated pupil constriction amplitude 39 in response to long wavelength pulsed stimulation, and reduced post-illumination pupil 40 response (PIPR) amplitude in response to both short wavelength pulsed and sinusoidal 41 stimulation. In the PD group, PIPR amplitude did not correlate with measures of sleep 42 quality, retinal nerve fibre layer thickness, UPDRS or H&Y score, or medication dosage.
Introduction
with a mild to moderate disease severity (Unified Parkinson's Disease Rating Scale (Fahn et 124 al., 1987 , Ramaker et al., 2002 ; Hoehn & Yahr (Hoehn and Yahr, 1967) ) and were 125 independent and cognitively intact (Mini-Mental State Examination (Folstein et al., 1975) . 126 All people with Parkinson's disease were optimally medicated during all measurements 127 (Table 1) Light stimuli were generated using a custom built extended Maxwellian-view optical system 152 (Beer et al., 2005 , Kankipati et al., 2010 , Joyce et al., 2015 , Joyce et al., 2016 . The light constriction amplitude for short wavelength pulsed stimulation was similar between the PD 275 (median = 43.35%, interquartile range = 10.57%) and control groups (39.93%, 2.79%) (p =
276
.079), whereas the minimum constriction amplitude for long wavelength pulsed stimulation 277 was reduced in the PD group (51.48%, 9.73%) compared to the control group (46.10%, 278 6.05%) (p = .034). The melanopsin-mediated PIPR amplitude was measured in the pulsed 279 and sinusoidal pupillometry protocols. For short wavelength stimuli that have a high 280 melanopsin excitation, the pulsed PIPR amplitude was 14.73% higher in Parkinson's disease 281 participants (80.32%, 23.16%) compared to controls (65.59%, 20.52%) (p = .018), indicating 282 reduced melanopsin contributions to this process (i.e., closer to baseline diameter in the PD 283 group than controls). Similarly, short wavelength sinusoidal PIPR amplitude was 12.96% 284 higher in the PD group (81.72%, 15.21%) compared to controls (68.76%, 21.32%)(p = .011).
285
As expected, the long wavelength (with minimal melanopsin excitation) PIPR amplitude was 286 not different between groups for either pulsed (p = .325) or sinusoidal (p = .556) stimulation. Asterisks indicate a significant difference between groups (p < .05).
292
Spearman's rank-order correlations were performed to determine if the short wavelength 293 pulsed PIPR amplitude was associated in the PD group with sleep quality (PSQI), symptom 294 severity (UPDRS), retinal nerve fibre layer thickness (RNFL) or medication dosage (LEDD); 295 no statistically significant correlations were observed (Table 2) . 
301
In response to sinusoidal stimulation, the peak to trough amplitude and the phase amplitude 302 percentage (PAP) of the phasic pupil response (Fig. 3) shows more variability in participants 303 with Parkinson's disease than controls, independent of stimulus wavelength. With short 304 wavelength lights that have high melanopsin excitation (Fig. 3A ) the peak to trough 305 amplitude trended to increase in the PD group (7.95%, 3.57%), which is indicative of reduced 306 melanopsin contributions compared to controls (5.59%, 2.20%), but this difference was not 307 significant (p = .205). Similarly, under long wavelength stimulation with low melanopsin 308 excitation (Fig. 3A) , the peak to trough amplitude did not differ between the PD group 309 (12.03%, 6.41%) and controls (11.48%, 3.18%) (p = .471). The median PAP did not 310 significantly different between groups (p = .537; Fig. 3B ). individual tracing are given in Table 3 ; the PD and control groups did not statistically differ 317 on any metric. 
318

Discussion
